What's new in hormone replacement therapy: focus on transdermal estradiol and micronized progesterone

By Simon J. A.  

Climacteric, Vol. 15, Iss. 1, 2012-04 ,pp. : 3-10

Informa Healthcare

Access to resources Recommend Favorite

Postmenopausal hormone replacement therapy and cardiovascular disease: the value of transdermal estradiol and micronized progesterone

By Mueck A. O.  

Climacteric, Vol. 15, Iss. 1, 2012-04 ,pp. : 11-17

Informa Healthcare

Access to resources Recommend Favorite

Risk of cardiovascular outcomes in users of estradiol/dydrogesterone or other HRT preparations

By Schneider C.   Jick S. S.   Meier C. R.  

Climacteric, Vol. 12, Iss. 5, 2009-10 ,pp. : 445-453

Informa Healthcare

Access to resources Recommend Favorite

Acceptability and patterns of endometrial bleeding in estradiol-based HRT regimens: a comparative study of cyclical sequential combinations of trimegestone or norethisterone acetate

By Al-Azzawi F.   Wahab M.   Thompson J.   Pornel B.   Hirvonen E.   Ylikorkala O.   van der Mooren M. J.   Dillon J.   Magaril C.  

Climacteric, Vol. 4, Iss. 4, 2001-12 ,pp. : 343-354

Informa Healthcare

Access to resources Recommend Favorite

Influence of a continuous combined HRT (2 mg estradiol valerate and 2 mg dienogest) on postmenopausal depression

By Rudolph I   Palombo-Kinne E   Kirsch B   Mellinger U   Breitbarth H   Gräser T  

Climacteric, Vol. 7, Iss. 3, 2004-09 ,pp. : 301-311

Informa Healthcare

Access to resources Recommend Favorite